Roxampex 10 mg/10 mg/8 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 10 mg/10 mg/8 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 10 mg/10 mg/8 mg

Roxampex 20 mg/5 mg/4 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 20 mg/5 mg/4 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 20 mg/5 mg/4 mg

Roxampex 20 mg/5 mg/8 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 20 mg/5 mg/8 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 20 mg/5 mg/8 mg

Roxampex 20 mg/10 mg/8 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 20 mg/10 mg/8 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 20 mg/10 mg/8 mg

Roxampex 10 mg/5 mg/4 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 10 mg/5 mg/4 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 10 mg/5 mg/4 mg

Roxampex 10 mg/5 mg/8 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

roxampex 10 mg/5 mg/8 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - rosuvastatinum, amlodipinum, tert-butylamini perindoprilum - apvalkotā tablete - 10 mg/5 mg/8 mg

Jyseleca União Europeia - letão - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Orfarin 3 mg tabletes Letônia - letão - Zāļu valsts aģentūra

orfarin 3 mg tabletes

orion corporation, finland - varfarīna nātrija sāls - tablete - 3 mg

Orfarin 5 mg tabletes Letônia - letão - Zāļu valsts aģentūra

orfarin 5 mg tabletes

orion corporation, finland - varfarīna nātrija sāls - tablete - 5 mg

Begsan 25 mg/g gels Letônia - letão - Zāļu valsts aģentūra

begsan 25 mg/g gels

grindeks, as, latvia - ketoprofēns - gels - 25 mg/g